Emily Bernstein
Affiliations: | Cancer Biology | Icahn School of Medicine at Mount Sinai, New York, NY, United States |
Area:
Biochemistry, Molecular Biology, Human DevelopmentGoogle:
"Emily Bernstein"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Gregory J. Hannon | grad student | CSHL | |
| C. David Allis | post-doc | Rockefeller |
Children
Sign in to add trainee| Avnish Kapoor | grad student | 2011 | Mount Sinai |
| Kajan Ratnakumar | grad student | 2012 | Mount Sinai |
| Hsan-au Wu | grad student | 2014 | Mount Sinai School of Medicine |
| Luis F. Duarte | grad student | 2015 | Mount Sinai School of Medicine |
| Alexandre Gaspar-Maia | post-doc | 2010-2017 | Mount Sinai School of Medicine (Neurotree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Jostes S, Vardabasso C, Dong J, et al. (2024) H2A.Z chaperones converge on E2F target genes for melanoma cell proliferation. Genes & Development |
| Mendelson K, Martin TC, Nguyen CB, et al. (2024) Differential histone acetylation and super-enhancer regulation underlie melanoma cell dedifferentiation. Jci Insight |
| Jostes S, Vardabasso C, Dong J, et al. (2023) H2A.Z chaperones converge on histone H4 acetylation for melanoma cell proliferation. Biorxiv : the Preprint Server For Biology |
| Filipescu D, Carcamo S, Agarwal A, et al. (2023) MacroH2A restricts inflammatory gene expression in melanoma cancer-associated fibroblasts by coordinating chromatin looping. Nature Cell Biology |
| Mohammed Ismail W, Mazzone A, Ghiraldini FG, et al. (2023) MacroH2A histone variants modulate enhancer activity to repress oncogenic programs and cellular reprogramming. Communications Biology. 6: 215 |
| Bernstein E, Dent S, Dou Y, et al. (2023) C. David Allis (1951-2023). Molecular Cell. 83: 497-499 |
| Bernstein E, Dent S, Dou Y, et al. (2023) C. David Allis (1951-2023). Cell. 186: 663-667 |
| Schoenfeld DA, Zhou R, Zairis S, et al. (2022) Loss of PBRM1 alters promoter histone modifications and activates ALDH1A1 to drive renal cell carcinoma. Molecular Cancer Research : McR |
| Carcamo S, Nguyen CB, Grossi E, et al. (2022) Altered BAF occupancy and transcription factor dynamics in PBAF-deficient melanoma. Cell Reports. 39: 110637 |
| Lecce L, Xu Y, V'Gangula B, et al. (2021) Histone deacetylase 9 promotes endothelial-mesenchymal transition and an unfavorable atherosclerotic plaque phenotype. The Journal of Clinical Investigation. 131 |